Upregulation of microRNA-7 contributes to inhibition of the growth and metastasis of osteosarcoma cells through the inhibition of IGF1R

被引:14
|
作者
Zhang, Zuojun [1 ]
Zhao, Ming [1 ]
Wang, Guojie [1 ]
机构
[1] Luoyang Orthoped Hosp Henan Prov, Upper Limb Injury Treatment Ctr, Orthoped Hosp Henan Prov, Luoyang 471002, Peoples R China
关键词
growth; IGF1R; invasion; lung metastasis; metastasis; microRNA-7; osteosarcoma; promoter methylation; FACTOR RECEPTOR; TUMOR-SUPPRESSOR; MIGRATION; INSULIN; PROLIFERATION; EXPRESSION; INVASION; CANCER; APOPTOSIS;
D O I
10.1002/jcp.28787
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We aim to uncover the methylation of microRNA-7 (miR-7) promoter in osteosarcoma (OS) and the inner mechanism of miR-7 on the progression of OS cells. Expression and methylation state of miR-7 in OS tissues and cells were detected. With the aim to unearth the ability of miR-7 in OS, the proliferation, cell cycle progression, apoptosis, invasion, migration of OS cells, and the tumor growth in nude mice were determined. Meanwhile, IGF1R expression was detected and the association between miR-7 and IGF1R was confirmed. The proliferating cell nuclear antigen (PCNA) expression was tested by immunohistochemical staining, and the lung metastasis was observed by H&E staining. miR-7 expression was decreased and methylation state of miR-7 was increased in OS tissues and cells. Upregulated miR-7 inhibited proliferation, cell cycle progression, invasion,and migration, while inducing apoptosis of OS cells and the tumor growth as well as PCNA expression in nude mice. Expression of IGF1R was downregulated in OS cells with overexpression of miR-7. Experiments verified the binding site between miR-7 and IGF1R. Our study demonstrates that abnormal methylation of miR-7 contributes to decreased miR-7 in OS. In addition, miR-7 represses the initiation and progression of OS cells through the inhibition of IGF1R.
引用
收藏
页码:22195 / 22206
页数:12
相关论文
共 50 条
  • [41] ENHANCED EFFICACY OF IGF1R INHIBITION IN PAEDIATRIC GLIOBLASTOMA BY COMBINATORIAL TARGETING OF PDGFRALPHA/BETA
    Bielen, A. B.
    Perryman, L.
    Box, G.
    Valenti, M.
    Brandon, A. de Haven
    Popov, S.
    Hofmann, F.
    Hargrave, D.
    Eccles, S.
    Jones, C.
    NEURO-ONCOLOGY, 2010, 12 (06) : II44 - II44
  • [42] ENHANCED EFFICACY OF IGF1R INHIBITION IN PEDIATRIC GLIOBLASTOMA BY COMBINATORIAL TARGETING OF PDGFRALPHA/BETA
    Bielen, Aleksandra
    Perryman, Lara
    Box, Gary
    Popov, Sergey
    Jeay, Sebastein
    Hofmann, Francesco
    Hargrave, Darren
    Eccles, Sue
    Jones, Chris
    NEURO-ONCOLOGY, 2010, 12 : 84 - 85
  • [43] Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors
    Stalnecker, Clint A.
    Grover, Kajal R.
    Edwards, A. Cole
    Coleman, Michael F.
    Yang, Runying
    DeLiberty, Jonathan M.
    Papke, Bjorn
    Goodwin, Craig M.
    Pierobon, Mariaelena
    Petricoin, Emanuel F., III
    Gautam, Prson
    Wennerberg, Krister
    Cox, Adrienne D.
    Der, Channing J.
    Hursting, Stephen D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2022, 82 (04) : 586 - 598
  • [44] Picropodophyllotoxin alters EMT in neuroblastoma via inhibition of surface receptors IGF1R and ALK
    Bhagriya, Poonam
    Shaikh, Afridi
    Roy, Hetal
    GROWTH HORMONE & IGF RESEARCH, 2025, 80
  • [45] Effects of Src and IGF1R inhibition on acquired endocrine therapy resistant breast cancer
    Liu, Shuyling
    Meng, Xiaolong
    Liu, Wenbin
    Miller, Todd
    Lu, Yiling
    Zhang, Fan
    Arteaga, Carlos L.
    Mills, Gordon B.
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72
  • [46] The insulin-like growth factor 1 receptor (IGF1R) contributes to reduced size in dogs
    Barbara C. Hoopes
    Maud Rimbault
    David Liebers
    Elaine A. Ostrander
    Nathan B. Sutter
    Mammalian Genome, 2012, 23 : 780 - 790
  • [47] The insulin-like growth factor 1 receptor (IGF1R) contributes to reduced size in dogs
    Hoopes, Barbara C.
    Rimbault, Maud
    Liebers, David
    Ostrander, Elaine A.
    Sutter, Nathan B.
    MAMMALIAN GENOME, 2012, 23 (11-12) : 780 - 790
  • [48] KiSS1 inhibits growth and invasion of osteosarcoma cells through inhibition of the MAPK pathway
    Zhang, Y.
    Tang, Y. J.
    Li, Z. H.
    Pan, F.
    Huang, K.
    Xu, G. H.
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2013, 57 (04): : 199 - 204
  • [49] Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells
    Mcdermott, Martina S. J.
    Canonici, Alexandra
    Ivers, Laura
    Browne, Brigid C.
    Madden, Stephen F.
    O'Brien, Neil A.
    Crown, John
    O'Donovan, Norma
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (06) : 2221 - 2228
  • [50] Inhibition Of IGF1R by IGF-1R/IR Inhibitor OSI906 as a Targeted Therapy for Glioblastoma: In Vitro & in Vivo Studies
    Fernandez, M. C.
    Martin, A.
    Clement, F.
    Venara, M. C.
    Garcia Lombardi, M.
    Bergada, I
    Gutierrez, M.
    Pennisi, P. A.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 92 : 12 - 12